Tags: barrons | cool | refrigeration | vaccination | vaccine | delivery

Barron's: 5 Stocks for the COVID-19 Vaccine Era

Barron's: 5 Stocks for the COVID-19 Vaccine Era
(Rolffimages/Dreamstime)

By    |   Tuesday, 10 November 2020 09:04 AM

Barron’s reports that the next hot thing in the fight against COVID-19 could turn out to be refrigerators.

Pfizer (PFE) and BioNTech’s (BNTX) news that they have an apparently effective vaccine has the potential to benefit many sectors. Cooling technology is on the list because the vaccine needs to be kept cold, Barron’s said.

UBS analyst Markus Mittermaier recently hosted a conference call with Dr. Jean-Pierre Emond, CEO at Blueye. a so-called cold-chain logistics company.

“Dr. Emond discussed COVID-19 vaccine candidates—notably Pfizer [and] BioNTech—requiring minus 70 to minus 80 degree Celsius transportation/storage,” wrote Mittermaier in a Monday research report.

The freezer in a typical refrigerator is set at about minus 20 Celsius. Dry ice, or solidified carbon dioxide, is about minus 78 Celsius, Shipping early COVID-19 vaccines will require some specialized handling.

“Trane Technologies (TT) and Carrier Global (CARR) are two firms that sell refrigeration technology for transportation. Knight-Swift Transportation (KNX) is a logistics carrier offering refrigerated trucking, among other types of shipping. And United Parcel Service (UPS) as well as FedEx (FDX) have temperature- sensitive health-care shipping businesses,” Barrons said.

Meanwhile, BioNTech is planning to price the two-shot regimen below "typical market rates" and would differentiate pricing between countries or regions.

Speaking at a Financial Times online event, the German biotech firm's strategy head Ryan Richardson said the price tag of the vaccine, which is co-developed with Pfizer and which has yet to win regulatory approval, would reflect the financial risks that its private-sector investors have incurred, Reuters said.

"We've tried to pursue a balanced approach that recognizes that innovation requires capital and investment so we plan to price our vaccine well below typical market rates reflecting the situation that we're in and with the goal to insure broad-based access around the world," Richardson said at the FT event.

"I expect there to be differential pricing in certain regions of the world," he added, declining to elaborate on the different price tags.

The vaccine was on Monday shown to be 90% effective, based on preliminary trial results, a key milestone in the war against a virus that has killed over a million people and battered the world's economy.

© 2021 Newsmax Finance. All rights reserved.


   
1Like our page
2Share
StreetTalk
Barron's reports that the next hot thing in the fight against COVID-19 could turn out to be refrigerators.
barrons, cool, refrigeration, vaccination, vaccine, delivery
359
2020-04-10
Tuesday, 10 November 2020 09:04 AM
Newsmax Media, Inc.
 
Newsmax TV Live

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved